News Release

<< Back
Ra Pharmaceuticals to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 31, 2017-- Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the following upcoming investor conferences:

  • The Credit Suisse 26th Annual Healthcare Conference on Tuesday, November 7, 2017 at 9:10 a.m. M.T. The conference is being held at the Phoenician Resort in Scottsdale, AZ.
  • The Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at 4:15 p.m. E.T. The conference is being held at the Lotte New York Palace Hotel.
  • The Jefferies Global Healthcare Conference on Thursday, November 16, 2017 at 2:00 p.m. G.M.T.

Live webcasts of each presentation can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentations will also be available and archived on the site for three weeks following each presentation.

About Ra Pharmaceuticals

Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.

Source: Ra Pharmaceuticals, Inc.

Investors:
Ra Pharmaceuticals, Inc.
Jennifer Robinson, 617-674-9873
jrobinson@rapharma.com
or
Media:
Argot Partners
Eliza Schleifstein, 917-763-8106
eliza@argotpartners.com